| Primary |
| Hepatitis C |
41.6% |
| Malignant Melanoma |
27.4% |
| Drug Use For Unknown Indication |
6.5% |
| Product Used For Unknown Indication |
5.8% |
| Metastatic Renal Cell Carcinoma |
3.3% |
| Renal Cell Carcinoma Stage Unspecified |
2.7% |
| Multiple Myeloma |
2.0% |
| Renal Cancer Metastatic |
1.7% |
| Metastatic Malignant Melanoma |
1.4% |
| Renal Cell Carcinoma |
1.1% |
| Haemangioma |
1.0% |
| Malignant Melanoma Stage Iii |
1.0% |
| Hepatic Cirrhosis |
0.8% |
| Hepatitis B |
0.6% |
| Small Intestine Carcinoma |
0.6% |
| Chronic Hepatitis |
0.5% |
| Hiv Infection |
0.5% |
| Mycosis Fungoides |
0.5% |
| Renal Cancer |
0.5% |
| Allergic Granulomatous Angiitis |
0.4% |
|
| Weight Decreased |
19.0% |
| Vomiting |
12.1% |
| White Blood Cell Count Decreased |
12.1% |
| Neutropenia |
6.5% |
| Death |
5.6% |
| Neutrophil Count Decreased |
4.4% |
| Pyrexia |
4.0% |
| Urinary Incontinence |
3.6% |
| Cognitive Disorder |
3.2% |
| Convulsion |
3.2% |
| Myocardial Infarction |
3.2% |
| Asthenia |
2.8% |
| Nausea |
2.8% |
| Platelet Count Decreased |
2.8% |
| Cellulitis |
2.4% |
| Retinal Detachment |
2.4% |
| Thrombocytopenia |
2.4% |
| Tremor |
2.4% |
| Vision Blurred |
2.4% |
| Visual Acuity Reduced |
2.4% |
|
| Secondary |
| Hepatitis C |
43.4% |
| Hypertension |
6.8% |
| B-cell Lymphoma |
5.8% |
| Drug Use For Unknown Indication |
5.6% |
| Malignant Melanoma |
5.2% |
| Metastatic Renal Cell Carcinoma |
4.8% |
| Renal Cell Carcinoma Stage Unspecified |
3.6% |
| Renal Cell Carcinoma |
3.3% |
| Hiv Infection |
2.4% |
| Asthma |
2.1% |
| Chronic Myeloid Leukaemia |
2.1% |
| Gout |
1.9% |
| Hepatic Neoplasm Malignant |
1.9% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Constipation |
1.7% |
| Multiple Myeloma |
1.7% |
| Hepatitis C Virus Test Positive |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Blood Pressure |
1.5% |
| Insomnia |
1.3% |
|
| Pyrexia |
15.7% |
| Vomiting |
10.5% |
| Pancreatitis Acute |
8.7% |
| Weight Decreased |
7.6% |
| Finger Hypoplasia |
6.4% |
| White Blood Cell Count Decreased |
5.2% |
| Cerebral Infarction |
4.7% |
| Myelodysplastic Syndrome |
4.7% |
| Platelet Count Decreased |
4.1% |
| Rash |
4.1% |
| Thrombocytopenia |
4.1% |
| Death |
3.5% |
| Salmonella Sepsis |
3.5% |
| Pancytopenia |
2.9% |
| Type 1 Diabetes Mellitus |
2.9% |
| Drug Ineffective |
2.3% |
| Hepatic Neoplasm Malignant |
2.3% |
| Lymph Node Tuberculosis |
2.3% |
| Malaise |
2.3% |
| Polymyositis |
2.3% |
|
| Concomitant |
| Hiv Infection |
12.4% |
| Hepatitis C |
11.8% |
| Multiple Myeloma |
10.4% |
| Diabetes Mellitus |
8.6% |
| Pain |
8.4% |
| Renal Cell Carcinoma |
5.2% |
| Hypertension |
4.9% |
| Metastases To Bone |
4.9% |
| Oral Infection |
4.3% |
| Constipation |
3.7% |
| Metastatic Renal Cell Carcinoma |
3.2% |
| Nuclear Magnetic Resonance Imaging |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Antiviral Prophylaxis |
2.9% |
| Hepatitis B |
2.9% |
| Depression |
2.3% |
| Premedication |
2.3% |
| Prophylaxis |
2.0% |
| Insomnia |
1.7% |
| Liver Transplant Rejection |
1.7% |
|
| Wound Drainage |
11.2% |
| Hepatic Fibrosis |
6.7% |
| Nephrogenic Systemic Fibrosis |
6.7% |
| Osteonecrosis |
6.7% |
| Platelet Count Decreased |
6.7% |
| Tooth Extraction |
6.7% |
| Vomiting |
6.7% |
| Rash |
5.6% |
| Hepatic Neoplasm Malignant |
4.5% |
| Liver Disorder |
4.5% |
| Hepatic Failure |
3.4% |
| Hepatitis C |
3.4% |
| Neoplasm Malignant |
3.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.4% |
| Peritonitis |
3.4% |
| Pyrexia |
3.4% |
| Rash Generalised |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Skin Discolouration |
3.4% |
| Weight Decreased |
3.4% |
|
